Analysis of neglected tropical disease drug and vaccine development pipelines to predict issuance of FDA priority review vouchers over the next decade.
Saved in:
Main Authors: | Rianna Stefanakis (Author), Andrew S Robertson (Author), Elizabeth L Ponder (Author), Melinda Moree (Author) |
---|---|
Format: | Book |
Published: |
Public Library of Science (PLoS),
2012-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The impact of the US priority review voucher on private-sector investment in global health research and development.
by: Andrew S Robertson, et al.
Published: (2012) -
Is the priority review voucher program stimulating new drug development for tropical diseases?
by: Kirk W Kerr, et al.
Published: (2018) -
The PLOS Neglected Tropical Diseases decade.
by: Peter Hotez, et al.
Published: (2017) -
Will COVID-19 become the next neglected tropical disease?
by: Peter J Hotez, et al.
Published: (2020) -
Current pipelines for neglected diseases.
by: Paolo di Procolo, et al.
Published: (2014)